Literature DB >> 28514449

Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators.

Gaojie Song1, Dehua Yang2, Yuxia Wang1, Chris de Graaf3, Qingtong Zhou1, Shanshan Jiang4, Kaiwen Liu1,5,6, Xiaoqing Cai2, Antao Dai2, Guangyao Lin5, Dongsheng Liu1, Fan Wu1,5,6, Yiran Wu1, Suwen Zhao1,5, Li Ye4, Gye Won Han7, Jesper Lau8, Beili Wu5,6,9, Michael A Hanson10, Zhi-Jie Liu1,5,11, Ming-Wei Wang2,4,5, Raymond C Stevens1,5.   

Abstract

The glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR) are members of the secretin-like class B family of G-protein-coupled receptors (GPCRs) and have opposing physiological roles in insulin release and glucose homeostasis. The treatment of type 2 diabetes requires positive modulation of GLP-1R to inhibit glucagon secretion and stimulate insulin secretion in a glucose-dependent manner. Here we report crystal structures of the human GLP-1R transmembrane domain in complex with two different negative allosteric modulators, PF-06372222 and NNC0640, at 2.7 and 3.0 Å resolution, respectively. The structures reveal a common binding pocket for negative allosteric modulators, present in both GLP-1R and GCGR and located outside helices V-VII near the intracellular half of the receptor. The receptor is in an inactive conformation with compounds that restrict movement of the intracellular tip of helix VI, a movement that is generally associated with activation mechanisms in class A GPCRs. Molecular modelling and mutagenesis studies indicate that agonist positive allosteric modulators target the same general region, but in a distinct sub-pocket at the interface between helices V and VI, which may facilitate the formation of an intracellular binding site that enhances G-protein coupling.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28514449     DOI: 10.1038/nature22378

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  48 in total

1.  Functional elements of the gastric inhibitory polypeptide receptor: Comparison between secretin- and rhodopsin-like G protein-coupled receptors.

Authors:  Arnau Cordomí; Sadek Ismail; Minos-Timotheos Matsoukas; Chantal Escrieut; Marie-Julie Gherardi; Leonardo Pardo; Daniel Fourmy
Journal:  Biochem Pharmacol       Date:  2015-06-01       Impact factor: 5.858

2.  GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit.

Authors:  Sander Pronk; Szilárd Páll; Roland Schulz; Per Larsson; Pär Bjelkmar; Rossen Apostolov; Michael R Shirts; Jeremy C Smith; Peter M Kasson; David van der Spoel; Berk Hess; Erik Lindahl
Journal:  Bioinformatics       Date:  2013-02-13       Impact factor: 6.937

3.  A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice.

Authors:  Desu Chen; Jiayu Liao; Na Li; Caihong Zhou; Qing Liu; Guangxing Wang; Rui Zhang; Song Zhang; Lilin Lin; Kaixian Chen; Xin Xie; Fajun Nan; Andrew A Young; Ming-Wei Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-09       Impact factor: 11.205

Review 4.  Insights into the structure of class B GPCRs.

Authors:  Kaspar Hollenstein; Chris de Graaf; Andrea Bortolato; Ming-Wei Wang; Fiona H Marshall; Raymond C Stevens
Journal:  Trends Pharmacol Sci       Date:  2013-12-18       Impact factor: 14.819

5.  Scanning of the glucagon-like peptide-1 receptor localizes G protein-activating determinants primarily to the N terminus of the third intracellular loop.

Authors:  S K Mathi; Y Chan; X Li; M B Wheeler
Journal:  Mol Endocrinol       Date:  1997-04

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  A hydrophobic site on the GLP-1 receptor extracellular domain orients the peptide ligand for signal transduction.

Authors:  James T Patterson; Pengyun Li; Jonathan W Day; Vasily M Gelfanov; Richard D Dimarchi
Journal:  Mol Metab       Date:  2013-01-16       Impact factor: 7.422

8.  Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human islets.

Authors:  Kyle W Sloop; Francis S Willard; Martin B Brenner; James Ficorilli; Kathleen Valasek; Aaron D Showalter; Thomas B Farb; Julia X C Cao; Amy L Cox; M Dodson Michael; Sonia Maria Gutierrez Sanfeliciano; Mark J Tebbe; Michael J Coghlan
Journal:  Diabetes       Date:  2010-09-07       Impact factor: 9.461

9.  Crystal structure of the β2 adrenergic receptor-Gs protein complex.

Authors:  Søren G F Rasmussen; Brian T DeVree; Yaozhong Zou; Andrew C Kruse; Ka Young Chung; Tong Sun Kobilka; Foon Sun Thian; Pil Seok Chae; Els Pardon; Diane Calinski; Jesper M Mathiesen; Syed T A Shah; Joseph A Lyons; Martin Caffrey; Samuel H Gellman; Jan Steyaert; Georgios Skiniotis; William I Weis; Roger K Sunahara; Brian K Kobilka
Journal:  Nature       Date:  2011-07-19       Impact factor: 49.962

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  60 in total

Review 1.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

2.  Fluorescent bioorthogonal labeling of class B GPCRs in live cells.

Authors:  Srikanth Kumar Gangam; Qing Lin
Journal:  Methods Enzymol       Date:  2020-06-15       Impact factor: 1.600

3.  Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMP.

Authors:  Oleg G Chepurny; Minos-Timotheos Matsoukas; George Liapakis; Colin A Leech; Brandon T Milliken; Robert P Doyle; George G Holz
Journal:  J Biol Chem       Date:  2019-01-08       Impact factor: 5.157

4.  Does the Lipid Bilayer Orchestrate Access and Binding of Ligands to Transmembrane Orthosteric/Allosteric Sites of G Protein-Coupled Receptors?

Authors:  Christopher T Szlenk; Jeevan B Gc; Senthil Natesan
Journal:  Mol Pharmacol       Date:  2019-04-08       Impact factor: 4.436

5.  Thioamide Substitution Selectively Modulates Proteolysis and Receptor Activity of Therapeutic Peptide Hormones.

Authors:  Xing Chen; Elizabeth G Mietlicki-Baase; Taylor M Barrett; Lauren E McGrath; Kieran Koch-Laskowski; John J Ferrie; Matthew R Hayes; E James Petersson
Journal:  J Am Chem Soc       Date:  2017-11-13       Impact factor: 15.419

6.  A free-energy landscape for the glucagon-like peptide 1 receptor GLP1R.

Authors:  Raphael Alhadeff; Arieh Warshel
Journal:  Proteins       Date:  2019-08-02

Review 7.  Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure.

Authors:  Yana Anfinogenova; Elena V Grakova; Maria Shvedova; Kristina V Kopieva; Alexander T Teplyakov; Sergey V Popov
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214

8.  A benchmark study of loop modeling methods applied to G protein-coupled receptors.

Authors:  Lee H Wink; Daniel L Baker; Judith A Cole; Abby L Parrill
Journal:  J Comput Aided Mol Des       Date:  2019-05-23       Impact factor: 3.686

Review 9.  Ligand binding at the protein-lipid interface: strategic considerations for drug design.

Authors:  Jian Payandeh; Matthew Volgraf
Journal:  Nat Rev Drug Discov       Date:  2021-07-13       Impact factor: 84.694

10.  Lipid-Protein Interactions Are a Unique Property and Defining Feature of G Protein-Coupled Receptors.

Authors:  Besian I Sejdiu; D Peter Tieleman
Journal:  Biophys J       Date:  2020-03-20       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.